ANSWER: A
Bleeding is the most common and clinically relevant complication after a kidney biopsy. Studies from 1970s and 1980s have shown radiologic (CT) evidence of bleeding in 57%-91% of patients, depending on the use of older scanners, biopsy techniques, and needles.
References:
- Hogan JJ, Mocanu M and Berns JS. The Native Kidney Biopsy: Update and Evidence for Best Practice. Clin J Am Soc Nephrol 11: 354-362, 2016.
- Ralls PW, Barakos JA, Kaptein EM, Friedman PE, et al. Renal biopsy-related hemorrhage: Frequency and comparison of CT and sonography. J Comput Assist tomog 11: 1031-1034, 1987.
- Alter AJ, Zimmerman S, Kirachaiwanich C. Computerized tomographic assessment of retroperitoneal hemorrhage after percutaneous renal biopsy. Arch Intern Med 140: 1323-1326, 1980.
- Rosenbaum R, Hoffsten PE, Stanely RJ, Klahr S. Use of computerized tomography to diagnose complications of percutaneous renal biopsy. Kidney Int 14: 87-92, 1978.
Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.
